PHOtonic integrated OCT-enhanced flow cytometry for canceR and cardiovascular diagnostics enabled by Extracellular VEsicles discRimination
PHOREVER is a research and innovation action that aims to develop a disruptive multi-sensing platform with a great medical impact. The platform will enable for the first time the reliable detection of EVs with size down to 140 nm, the detection of EVs with specific biomarkers (proteins) on their surface, and the calculation of the corresponding EV concentrations in the blood while data analysis empowered by artificial intelligence will correlate the measurement data to disease specific medical information.
A recent open-access study published in Frontiers in Oncology highlights a novel, non-invasive approach for classifying pancreatic neoplasms using machine learning and plasma-derived extracellular vesicles
We’re proud to share that the PHOREVER Project was recently represented at the Gordon Research Conference on Physics and Chemistry of Microfluidics, held in Lucca,
Topic: HORIZON-CL4-2022-DIGITAL-EMERGING-01-03 – Advanced multi-sensing systems (Photonics Partnership) (RIA)
Programme Call: HORIZON-CL4-2022-DIGITAL-EMERGING-01
Project number: 101093171
Start date: 1 January 2023
Duration: 42 months
EU contribution: € 4 973 882,50
Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union. Neither the European Union nor the granting authority can be held responsible for them.
